Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus

Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus

Abstract Background While neoadjuvant chemoradiation therapy (nCRT) with subsequent surgery is the treatment of choice for patients with locally advanced or node-positive squamous cell carcinoma of the esophagus (SCC) suitable for surgery, patients who are unsuitable for surgery or who refuse surger...

Full description

Bibliographic Details
Main Authors: Stefan Münch, Steffi U. Pigorsch, Michal Devečka, Hendrik Dapper, Wilko Weichert, Helmut Friess, Rickmer Braren, Stephanie E. Combs, Daniel Habermehl
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Radiation Oncology
Subjects:
Squamous cell carcinoma of the esophagus
Definite chemoradiation
Cisplatin/5-fluoruracil
Carboplatin/paclitaxel
Online Access:http://link.springer.com/article/10.1186/s13014-018-1085-z

Internet

http://link.springer.com/article/10.1186/s13014-018-1085-z

Similar Items